The Scientific World Journal / 2015 / Article / Tab 2 / Research Article
Multivariate Statistical Analysis as a Supplementary Tool for Interpretation of Variations in Salivary Cortisol Level in Women with Major Depressive Disorder Table 2 Characteristic features of four groups of patients under antidepressant therapy displayed by HCA dendrogram.
HCA cluster Antidepressant Number of patients Age of patients, years Multiplicity of hospitalization Hospitalization period, days Initial and final cortisol levels, ng/mL Highest and lowest cortisol levels, ng/mL Mean cortisol level, ng/mL Median for cortisol level, ng/mL Cluster Ia TCAs 5 51 3 29 16.57–9.67 1.25–26.25 10.80 8.44 SSRIs 9 49 2 63 17.33–4.83 2.00–31.50 8.51 6.94 SNRIs 2 44 1 59 15.00–5.53 1.25–24.75 8.50 7.53 SSAs 3 39 2 66 20.58–5.21 1.25–24.25 9.30 8.75 NaSSAs 1 63 1 21 33.00–8.62 6.25–33.00 17.50 8.62 SSREs 1 28 7 46 27.50–9.25 1.75–27.50 8.62 7.62 Others psychoactive drugs 4 44 3 25 12.56–7.92 1.37–21.25 7.59 6.69 Polypragmasy 3 50 2 40 11.79–2.42 1.25–15.62 5.48 6.00 Cluster Ib TCAs 4 55 1 71 31.06–11.59 1.25–55.00 12.98 9.15 SSRIs 7 46 2 48 32.99–11.05 1.25–49.75 11.78 7.50 SNRIs 5 45 2 63 33.80–12.57 1.25–62.50 9.31 4.00 SSAs 1 57 2 46 29.50–2.87 1.25–29.50 6.34 4.62 SARIs 2 42 5 80 27.50–7.19 1.25–37.50 9.13 7.34 SSREs 2 47 2 21 47.00–20.31 1.75–52.00 16.24 10.69 RIMA 1 50 5 23 37.50–5.62 1.25–37.50 10.41 6.12 Others psychoactive drugs 4 42 3 31 34.75–7.70 1.25–38.75 11.84 6.25 Polypragmasy 9 48 3 39 38.46–5.10 1.25–46.25 9.15 7.53 Cluster II TCAs 2 60 1 28 86.86–6.62 1.62–87.70 22.26 10.53 SSRIs 6 49 3 46 77.59–15.71 1.25–95.00 14.19 7.62 SNRIs 5 45 1 38 82.25–7.85 2.50–91.00 20.97 10.00 SSAs 2 58 1 53 58.00–6.31 1.37–102.00 12.47 7.87 Polypragmasy 2 62 5 45 76.00–9.54 2.50–95.00 20.62 8.34 Cluster III TCAs 1 31 3 32 161.25–83.75 8.75–161.25 50.57 30.62 SSRIs 4 48 3 35 87.44–105.00 0.25–195.00 19.55 9.06 SNRIs 3 44 2 51 234.96–7.72 0.25–3.75 30.03 5.94 SSAs 1 53 6 29 195.00–151.25 5.00–195.00 26.03 11.25 SARIs 1 51 4 76 182.50–5.00 1.25–182.50 26.73 13.00 Others psychoactive drugs 2 45 2 33 366.27–41.25 1.25–133.50 16.97 7.28